Association of circulating tumor HPV16DNA levels and quantitative PET parameters in patients with HPV-positive head and neck squamous cell carcinoma

• Published in: Scientific reports 2024-02, Vol.14 (1), p.3278-3278, Article 3278
• Main Authors: Tatsumi, Mitsuaki, Tanaka, Hidenori, Takenaka, Yukinori, Suzuki, Motoyuki, Fukusumi, Takahito, Eguchi, Hirotaka, Watabe, Tadashi, Kato, Hiroki, Yachida, Shinichi, Inohara, Hidenori, Tomiyama, Noriyuki
• Format: Article
• Language: English
• Subjects: 692/4028; 692/53; Blood; Carcinoma, Squamous Cell - pathology; Deoxyribonucleic acid; DNA; Fluorodeoxyglucose F18 - metabolism; Head & neck cancer; Head and neck carcinoma; Head and Neck Neoplasms - diagnostic imaging; Heterogeneity; Human papillomavirus; Humanities and Social Sciences; Humans; Lesions; Lymph nodes; Metastases; multidisciplinary; Multiple regression analysis; Papillomavirus Infections - virology; Positron emission tomography; Positron Emission Tomography Computed Tomography - methods; Radiopharmaceuticals; Regression analysis; Science; Science (multidisciplinary); Squamous cell carcinoma; Squamous Cell Carcinoma of Head and Neck - diagnostic imaging; Tumor markers; Tumors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-53894-4

Circulating tumor DNA (ctDNA), which circulates in the blood after being shed from cancer cells in the body, has recently gained attention as an excellent tumor marker. The purpose of this study was to evaluate whether ct human papillomavirus (HPV) 16 DNA (ctHPV16DNA) levels were associated with quantitative PET parameters in patients with HPV-positive head and neck (HN) squamous cell carcinoma (SCC). Fifty patients with oropharyngeal SCC (OPSCC) and 5 with SCC of unknown primary (SCCUP) before treatment were included. They all underwent blood sampling to test ctHPV16DNA levels and FDG PET-CT examinations. Quantitative PET parameters included SUVmax, metabolic tumor volume (MTV), MTV of whole-body lesions (wbMTV), and 56 texture features. ctHPV16DNA levels were compared to texture features of primary tumors in OPSCC patients (Group A) or the largest primary or metastatic lymph node lesions in OPSCC and SCCUP patients (Group B) and to other PET parameters. Spearman rank correlation test and multiple regression analysis were used to confirm the associations between ctHPV16DNA levels and PET parameters. ctHPV16DNA levels moderately correlated with wbMTV, but not with SUVmax or MTV in Groups A and B. ctHPV16DNA levels exhibited a weak negative correlation with low gray-level zone emphasis in Groups A and B. Multiple regression analysis revealed that wbMTV and high gray-level zone emphasis were the significant factors for ctHPV16DNA levels in Group B. These results were not observed in Group A. This study demonstrated that ctHPV16DNA levels correlated with the whole-body tumor burden and tumor heterogeneity visualized on FDG PET-CT in patients with HPV-positive HNSCC.